VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
RLYB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
RLYBRallybio Corporation
$17.08$91M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRLYBQuarterly Financials

Rallybio Corporation (RLYB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Rallybio Corporation (RLYB) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

RLYB Income Statement

Quarterly statement

RLYB Income Statement

Rallybio Corporation (RLYB) annual income statement — 7-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue0212K222K212K212K212K38K299K299K0228K000000000
Revenue Growth %-100%0%484.21%-29.1%-29.1%--83.33%-------------
Cost of Goods Sold03K3.65M4.14M6.07M5.72M30K034K35K114K37K38K39K39K42K44K42K35K26K
COGS % of Revenue-1.42%1646.4%1954.25%2865.09%2700.47%78.95%-11.37%-50%---------
Gross Profit0209K-3.43M-3.93M-5.86M-5.51M8K299K265K-35K114K-37K-38K-39K-39K-42K-44K-42K-35K-26K
Gross Margin %-98.58%-1546.4%-1854.25%-2765.09%-2600.47%21.05%100%88.63%-50%---------
Gross Profit Growth %100%103.79%-43012.5%-1414.72%-2312.08%-15651.43%-92.98%908.11%797.37%10.26%392.31%11.9%13.64%7.14%-11.43%-61.54%-76%-82.61%-74.74%-
Operating Expenses5.65M4.94M2.98M2.99M4.2M4.16M11.62M12.37M17.3M19.75M21.11M19.36M20.08M18.37M17.09M18.86M17.61M14.32M12.31M9.98M
OpEx % of Revenue-2331.13%1341.89%1412.26%1978.77%1960.85%30568.42%4135.45%5785.95%-9259.65%---------
Selling, General & Admin4.89M6.07M2.98M2.99M4.2M4.16M4.26M4.13M4.39M6.85M5.19M6.08M6.95M7.17M6.3M6.75M7.48M6.67M6.22M5.02M
SG&A % of Revenue-2865.09%1341.89%1412.26%1978.77%1960.85%11213.16%1379.6%1467.56%-2275.44%---------
Research & Development758K68K3.65M4.14M6.07M5.72M7.36M8.24M12.91M12.9M15.92M13.29M13.13M11.2M10.79M12.11M10.14M7.65M6.09M4.96M
R&D % of Revenue-32.08%1646.4%1954.25%2865.09%2700.47%19355.26%2755.85%4318.39%-6984.21%---------
Other Operating Expenses0-1000K-1000K-1000K-1000K-1000K00000000000000
Operating Income-5.65M-4.73M-6.41M-6.92M-10.06M-9.67M-11.61M-12.07M-17.04M-19.79M-21.11M-19.36M-20.08M-18.37M-17.09M-18.86M-17.61M-14.32M-12.31M-9.98M
Operating Margin %--2232.55%-2888.29%-3266.51%-4743.87%-4561.32%-30547.37%-4035.45%-5697.32%--9259.65%---------
Operating Income Growth %43.79%51.05%44.76%42.61%40.96%51.13%45.02%37.69%15.18%-7.69%-23.53%-2.67%-14.01%-28.33%-38.8%-88.96%-67.28%-11.65%-22.07%-
EBITDA-5.65M-4.73M-6.41M-6.89M-10.03M-9.64M-11.58M-12.03M-17M-19.75M-21.08M-19.33M-20.05M-18.34M-17.05M-18.82M-17.57M-14.28M-12.28M-9.96M
EBITDA Margin %--2231.13%-2886.94%-3250%-4731.6%-4548.11%-30468.42%-4024.75%-5685.95%--9243.86%---------
EBITDA Growth %43.69%50.94%44.65%42.75%41%51.18%45.07%37.73%15.19%-7.73%-23.6%-2.7%-14.08%-28.43%-38.88%-89.03%-67.26%-11.52%-21.96%-
D&A (Non-Cash Add-back)5K3K3K35K26K28K30K32K34K35K36K37K38K39K39K42K44K42K35K26K
EBIT44.99M-4.73M-6.41M-6.92M-10.06M-9.67M-11.61M-12.07M-17.04M-19.79M-21.11M-19.36M-20.08M-18.37M-17.09M-18.86M-17.61M-14.32M-12.31M-9.98M
Net Interest Income218K201K560K462K523K644K811K986K1.14M1.28M1.45M1.54M1.61M1.55M1.07M0270K012K12K
Interest Income218K201K560K462K523K644K811K986K1.14M1.28M1.45M1.54M1.61M1.55M1.07M525K270K97K12K12K
Interest Expense000000000000000525K097K00
Other Income/Expense50.64M-3.54M560K22.94M354K231K564K600K799K758K870K989K1.45M1.06M888K490K32K-180K-102K-215K
Pretax Income44.99M-8.28M-5.85M16.02M-9.7M-9.44M-11.04M-11.47M-16.24M-19.03M-20.24M-18.37M-18.63M-17.32M-15.99M-18.37M-17.58M-14.5M-12.41M-10.2M
Pretax Margin %--3904.72%-2636.04%7554.72%-4576.89%-4452.36%-29063.16%-3834.78%-5430.1%--8878.07%---------
Income Tax1.32M0000000000000214K00000
Effective Tax Rate %2.94%0%0%0%0%0%0%0%0%0%0%0%0%0%-1.34%0%0%0%0%0%
Net Income43.66M-8.28M-5.85M16.02M-9.7M-9.44M-11.04M-11.47M-16.24M-19.03M-20.24M-18.37M-18.63M-17.32M-16.2M-18.37M-17.58M-14.5M-12.41M-10.2M
Net Margin %--3904.72%-2636.04%7554.72%-4576.89%-4452.36%-29063.16%-3834.78%-5430.1%--8878.07%---------
Net Income Growth %550.02%12.3%47.01%239.68%40.24%50.4%45.44%37.6%12.85%-9.88%-24.93%-0.02%-5.95%-19.45%-30.51%-80.17%-58.02%-9.21%-18.04%-
Net Income (Continuing)43.66M-8.28M-5.85M16.02M-9.7M-9.44M-11.04M-11.47M-16.24M-19.03M-20.24M-18.37M-18.63M-17.32M-16.2M-18.37M-17.58M-14.5M-12.41M-10.2M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)7.53-1.46-1.112.84-1.76-1.68-2.00-2.08-2.96-3.76-4.00-3.60-3.68-3.44-3.68-4.80-4.56-3.84-3.36-2.96
EPS Growth %527.84%13.1%44.5%236.54%40.54%55.32%50%42.22%19.57%-9.3%-8.7%25%19.3%10.42%-9.52%-62.16%-58.33%20%10.64%-
EPS (Basic)7.66-1.46-1.112.84-1.76-1.68-2.00-2.08-2.96-3.76-4.00-3.60-3.68-3.44-3.68-4.80-4.56-3.84-3.36-2.96
Diluted Shares Outstanding5.8M5.69M5.28M5.63M5.61M5.6M5.58M5.57M5.52M5.1M5.08M5.07M5.05M5.03M4.44M3.85M3.82M3.79M3.72M3.44M
Basic Shares Outstanding5.7M5.69M5.28M5.63M5.61M5.6M5.58M5.57M5.52M5.1M5.08M5.07M5.05M5.03M4.44M3.85M3.82M3.79M3.72M3.44M
Dividend Payout Ratio--------------------